Clinical Trial

Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)

Recruiting
View on ClinicalTrials.gov →
Summary
Aim to observe the application of MR-Linac for precision radiotherapy of tumours, analyse its therapeutic effect, toxic and side effects,Characteristics of dosimetric parameters etc.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-29; most recent amendment 2025-02-11.
Trial Details
NCT Number NCT06531681
Lead Sponsor The Second Affiliated Hospital of Hainan Medical University
Conditions Overall Response Rate, Oncology, Radiation Toxicity, Quality of Life
Enrollment 3,000 participants
Start Date 2023-08-19
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-13